In vitro and in vivo hypoglycemia effect of oxyberberine, a novel HO-1 agonist: A renewed evidence linking HO-1 to diabetes mellitus

Dou, YX; Ai, GX; Huang, RL; Huang, ZW; Li, YC; Liu, YH; Xie, JH; Chen, JN; Su, ZR

Xie, JH (通讯作者)，Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China.;Xie, JH; Chen, JN; Su, ZR (通讯作者)，Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou, Peoples R China.;Xie, JH (通讯作者)，Guangzhou Univ Chinese Med, Affiliated Hosp 2, State Key Lab Dampness Syndrome Chinese Med, Guangzhou, Peoples R China.;Xie, JH (通讯作者)，Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou, Peoples R China.

PHYTOMEDICINE, 2022; 101 ():

Abstract

Background: Oxyberberine (OBB), an important in vivo metabolite of berberine, exerts superior hypoglycemia effect. However, the underlying mechanism r......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索